Search

Your search keyword '"M. L. Simoons"' showing total 208 results

Search Constraints

Start Over You searched for: Author "M. L. Simoons" Remove constraint Author: "M. L. Simoons" Language undetermined Remove constraint Language: undetermined
208 results on '"M. L. Simoons"'

Search Results

1. The Effects of a Perindopril-Based Regimen in Relation to Statin Use on the Outcomes of Patients with Vascular Disease: a Combined Analysis of the ADVANCE, EUROPA, and PROGRESS Trials

2. Encouraging survival rates in patients with acute myocardial infarction treated with an intra-aortic balloon pump

Catalog

Books, media, physical & digital resources

3. Multimarker risk model containing troponin-T, interleukin 10, myeloperoxidase and placental growth factor predicts long-term cardiovascular risk after non-ST-segment elevation acute coronary syndrome

4. Abstracts

5. The Rationale and Design of the Perindopril Genetic Association Study (PERGENE): A Pharmacogenetic Analysis of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients with Stable Coronary Artery Disease

6. Meeting Report: ESC Forum on Drug Eluting Stents European Heart House, Nice, 27-28 September 2007

7. ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT

8. Prognostic significance of nonfatal myocardial reinfarction in survivors of a first infarction

9. Continuously improving the practice of cardiology

10. Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials

11. Which Factors Are Associated with the Application of Reperfusion Therapy in ST-Elevation Acute Coronary Syndromes?

12. Decline in ventricular function and clinical condition after mustard repair for transposition of the great arteries (a prospective study of 22?29 years)*1

13. Association of revascularisation with low mortality in non-ST elevation acute coronary syndrome, a report from GUSTO IV-ACS

14. Outcome of patients after surgical closure of ventricular septal defect at young age: longitudinal follow-up of 22-34 years

15. Aortic valve and aortic arch pathology after coarctation repair

16. Oral glycoprotein Iib/IIIa receptor inhibitors in patients with cardiovadcular disease: why were the results so unfavourable

17. Safety and efficacy of eptifibatide vs placebo in patients receiving thrombolytic therapy with streptokinase for acute myocardial infarction. A phase II dose escalation, randomized, double-blind study

18. Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation. Recommendations of the Task Force of the European Society of Cardiology Recommendations of the Task Force of the European Society of Cardiology

19. Safety and preliminary efficacy of one month glycoprotein IIb/IIIa inhibition with lefradafiban in patients with acute coronary syndromes without ST-elevation

20. Safety and prognostic value of early dobutamine-atropine stress echocardiography in patients with spontaneous chest pain and a non-diagnostic electrocardiogram

21. Myocardial infarction redefined- a consensus document of the joint European society of cardiology/American college of cardiology committee for the redefinition of myocardial infarction

22. Time-dependent diagnostic performance of a rapid troponin T version 2 bedside test in patients with acute coronary syndromes

23. Effects of Stroke on Medical Resource Use and Costs in Acute Myocardial Infarction

24. Impact of smoking cessation and smoking interventions in patients with coronary heart disease

25. Sustained benefit at 10-14 years follow-up after thrombolytic therapy in myocardial infarction

26. Platelet glycoprotein IIB/IIA receptor antagonists An asset for treatment of unstable coronary syndromes and coronary intervention

27. Risk Factors for In-hospital Nonhemorrhagic Stroke in Patients With Acute Myocardial Infarction Treated With Thrombolysis

28. Effect of adopting a new histological grading system of acute rejection after heart transplantation

29. Management of myocardial infarction: the proper priorities

30. Comparison of usefulness of computer assisted continuous 48-h 3-lead with 12-lead ECG ischaemia monitoring for detection and quantitation of ischaemia in patients with unstable angina

31. Cardiologists' Use of Clinical Information for Management Decisions for Patients with Unstable Angina: A Policy Analysis

32. Variation in the use of coronary angiography in patients with unstable angina is related to differences in patient population and availability of angiography facilities, without affecting prognosis

33. Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency: The GUSTO Enzyme Substudy

34. Implementation of a pre-hospital decision rule in general practice: Triage of patients with suspected myocardial infarction

35. Pre-hospital thrombolytic therapy with either alteplase or streptokinase

36. Coronary artery disease: prevention of progression and prevention of events

37. Pre-hospital triage of patients with suspected myocardial infarction

38. Randomized trial of a GPIIb/IIIa platelet receptor blocker in refractory unstable angina. European Cooperative Study Group

39. Serum C-reactive protein and infarct size in myocardial infarct patients with a closed versus an open infarct-related coronary artery after thrombolytic therapy

40. Changes in left ventricular function and wall thickness in heart transplant recipients and their relation to acute rejection: an assessment by digitised M mode echocardiography

41. Prehospital thrombolysis with alteplase (rt-PA) in acute myocardial infarction

42. Well shaped ST segment and risk of cardiovascular mortality

43. Abstract 3714: Heme Oxygenase 1 Determines the Outcome of Vulnerable Plaque

44. Which factors are associated with the application of reperfusion therapy in ST-elevation acute coronary syndromes?. Lessons from the Euro Heart Survey on Acute Coronary Syndromes I

45. Management of Acute Coronary Syndrome

46. Real-time transthoracic three-dimensional echocardiography provides additional information of left-sided AV valve morphology after AVSD repair

47. Prognostic value of dobutamine stress echocardiography in patients with previous coronary revascularisation

48. Decline in ventricular function and clinical condition after Mustard repair for transposition of the great arteries (a prospective study of 22-29 years)

49. Elevated troponin T and C-reactive protein predict impaired outcome for 4 years in patients with refractory unstable angina, and troponin T predicts benefit of treatment with abciximab in combination with PTCA

50. Cost effectiveness of eptifibatide in acute coronary syndromes; an economic analysis of Western European patients enrolled in the PURSUIT trial. The Platelet IIa/IIb in unstable Angina: Receptor Suppression Using Integrilin Therapy